An imidazole derivative that is an agonist of ADRENERGIC ALPHA-2 RECEPTORS. It is closely related to MEDETOMIDINE, which is the racemic form of this compound.
Phase 4 trials (22)
Phase 3 trials (6)
Other trials (6)